Optimizing the use of CROs by academia and small companies
Year: 2013
Type: article
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd4057
Institutions: Alzheimer's Drug Discovery Foundation, Icahn School of Medicine at Mount Sinai, Harvard University, Circuit Therapeutics (United States), Charles River Laboratories (United States), Stanford Medicine, Stanford University, National Institutes of Health, National Institute on Aging, Northwestern University
Language: English
Subfield: Management Information Systems
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2082839356
